Skip to main navigation Skip to search Skip to main content

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: The BRIGHT study

  • Ian W. Flinn
  • , Richard Van Der Jagt
  • , Brad S. Kahl
  • , Peter Wood
  • , Tim E. Hawkins
  • , David MacDonald
  • , Mark Hertzberg
  • , Yiu Lam Kwan
  • , David Simpson
  • , Michael Craig
  • , Kathryn Kolibaba
  • , Samar Issa
  • , Regina Clementi
  • , Doreen M. Hallman
  • , Mihaela Munteanu
  • , Ling Chen
  • , John M. Burke

Research output: Contribution to journal › Article › peer-review

585   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: The BRIGHT study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science